Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1983-06-29
1984-12-11
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544295, 544357, 544360, 544363, 544366, 544368, 546276, 424251, C07D24908, C07D40304, A61K 31495
Patent
active
044877730
ABSTRACT:
Phenoxyalkyl substituted-1,2,4-triazolones having anti-depressant properties typified by 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyethyl)- 2H-1,2,4-triazol-3(4H)-one are disclosed.
REFERENCES:
patent: 3381009 (1968-04-01), Palazzo et al.
patent: 3857845 (1974-12-01), Palazzo
patent: 4338317 (1982-07-01), Temple, Jr. et al.
patent: 4386091 (1983-05-01), Temple, Jr. et al.
Silvestrini, et al., Int. J. Neuropharmacol., 7, 587-599, (1968).
Fabre, et al., Current Therapeutic Research, 25(6), 827-834, (1979).
Lobeck, Jr. Walter G.
Temple, Jr. Davis L.
Gibson S. A.
Mead Johnson & Company
Rizzo Nicholas S.
Ryan Richard P.
Uloth Robert H.
LandOfFree
1,2,4-Triazol-3-one antidepressants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,4-Triazol-3-one antidepressants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,4-Triazol-3-one antidepressants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1462934